Home › Funds › Kynam Capital Management, LP › NRIX

Kynam Capital Management, LP position in NRIX

NURIX THERAPEUTICS INC · Health Care

Kynam Capital Management, LP reported holding 1,194,757 shares of NRIX (NURIX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$29.0M, representing 1.60% of its reported portfolio and ranking #16 among its reported holdings. Kynam Capital Management, LP has disclosed NRIX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)1.19M sh
Reported value held$28.98M
Portfolio Weight1.60%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's NRIX position evolved

Kynam Capital Management, LP first disclosed a stake in NRIX in Q1 2025 at 800,000 shares (US$9.5M). The position peaked in Q4 2025 at 1,970,357 shares, worth US$37.4M. Across 6 filings, Kynam Capital Management, LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,194,757 shares valued at US$29.0M. Notable position changes include a 47% increase in Q2 2025 (shares fell 19% over the following quarter), a 85% increase in Q3 2025 (shares rose 105% over the following quarter), a 39% trim in Q1 2026 (shares rose 57% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 800.00K $9.50M New
Q2 2025 1.17M $13.37M Add
Q3 2025 2.17M $20.04M Add
Q4 2025 1.97M $37.38M Reduce
Q1 2026 1.19M $18.52M Reduce
Q2 2026 1.19M $28.98M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRIX and 13F data

NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in NRIX — the largest reported positions include Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRIX

All NRIX fund holders →

FAQ

How long has Kynam Capital Management, LP held NRIX?

Kynam Capital Management, LP has disclosed NRIX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Kynam Capital Management, LP's current position in NRIX?

As of Q2 2026, Kynam Capital Management, LP holds 1.19M shares of NRIX (NURIX THERAPEUTICS INC), valued at $28.98M, representing 1.60% of its reported portfolio and ranking #16.

Has Kynam Capital Management, LP been buying or selling NRIX?

In the latest 13F filing (Q2 2026), Kynam Capital Management, LP held unchanged its position in NRIX. The position peaked in Q4 2025 at 1.97M shares.

Which other funds hold NRIX?

Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.